BioSpace News Archive

Eloxx Pharmaceuticals, Inc. (“Eloxx”), (ELOX) (Other OTC:SVOND) a clinical-stage biopharmaceutical company developing novel read-through drug candidates that are designed to treat rare and ultra-rare premature...

Long-term commitment will launch up to ten collaborative research studies using Science 37 decentralized Metasite™ model

The award highlights innovative collaborations between distributors and manufacturers that enhance processes, reduce costs and leverage advanced technologies or logistical practices.

EUSA Pharma announced the appointment of Rolf K Hoffmann to its Board of Directors.

These will add their extensive experience and networks to PTx team.

Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced it will report its financial and operational results for the third quarter ended January 31, 2018, on Thursday, March 15, 2018, after market close.